Celgene to work on GlobeImmune's cancer candidates
GlobeImmune (cancer and infectious disease therapeutics) has granted oncology company Celgene options to exclusively develop and commercialize its cancer programs worldwide.
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.